Chemo-Pharma (CPL) | Stock Overview & Key Data
Chemo-Pharma Performance Comparison
Stock Range
Today's Range
Low: ₹75.00
High: ₹78.70
on July 25, 2025
52 Week Range
Low: ₹52.25
High: ₹128.00
on July 25, 2024
on January 10, 2025
All-Time High: ₹128.00 on January 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR4.7B
EPS
6.02
P/E Ratio (TTM)
13.21
Forward P/E
N/A
P/B Ratio
2.96
PEG Ratio
N/A
Div. Yield
N/A
ROE
25.59%
Beta
0.346
Debt to Equity
44.70
Financial Highlights
Profitability
Gross Margin
31.19%
Operating Margin
10.65%
Profit Margin
10.92%
Returns and Earnings
Return on Assets (TTM)
6.80%
Return on Equity (TTM)
25.59%
EBITDA
INR360.6M
Net Income (TTM)
INR313.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR49.84
Quarterly Revenue Growth (YoY)
14.10%
Quarterly Earnings Growth (YoY)
-3.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Chemo-Pharma CPL | 4.75B Small-cap | 1.69% | 4.48% | -15.16% | -28.20% | -35.30% | 38.64% | 393.51% | 115.30% |
| Ashok Leyland ASHOKLEY | 728.26B Large-cap | -0.25% | -50.15% | -45.81% | -38.19% | -45.27% | -49.87% | -17.11% | 153.85% |
| Escorts Kubota ESCORTS | 382.71B Large-cap | -0.10% | 3.24% | 2.34% | 1.32% | 3.40% | -17.59% | 97.13% | 201.25% |
| Vst Tillers Tractors VSTTILLERS | 41.32B Small-cap | 8.92% | 24.75% | 22.27% | 4.42% | -12.80% | 4.92% | 71.13% | 236.89% |
| HMT HMT | 23.11B Small-cap | -5.28% | -7.55% | 19.72% | -3.19% | -4.98% | -29.18% | 158.00% | 265.56% |
| Uniparts India UNIPARTS | 18.29B Small-cap | -3.67% | -4.19% | 12.82% | 2.85% | -10.31% | -24.24% | 201.01% | 210.92% |
Ownership & Short Interest
Insider Ownership
70.34%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
35K
Average 90-Day Volume
37K
Chemo-Pharma Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Chemo-Pharma would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CPL's 52-week high and low?
- In the last 52 weeks, Chemo-Pharma reached a high of ₹128.00 (on January 10, 2025) and a low of ₹52.25 (on July 25, 2024).
- What is the market cap and P/E ratio for CPL?
- Curious about Chemo-Pharma's size and valuation? Its market capitalization stands at 4.75B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.21, and the forward P/E (looking ahead) is N/A.
- Does CPL pay dividends? If so, what's the yield?
- As for dividends, Chemo-Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Chemo-Pharma's main competitors or similar companies to consider before investing?
When looking at Chemo-Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ashok Leyland
ASHOKLEY728.26B Industrials Farm & Heavy Construction Machinery -49.87% -17.11% Escorts Kubota
ESCORTS382.71B Industrials Farm & Heavy Construction Machinery -17.59% 97.13% Vst Tillers Tractors
VSTTILLERS41.32B Industrials Farm & Heavy Construction Machinery 4.92% 71.13% HMT
HMT23.11B Industrials Farm & Heavy Construction Machinery -29.18% 158.00% Uniparts India
UNIPARTS18.29B Industrials Farm & Heavy Construction Machinery -24.24% 201.01% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Chemo-Pharma Laboratories Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Chemo-Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 25.59%, the Debt to Equity ratio from the most recent quarter is 44.70, and its Gross Profit Margin stands at 31.19%.
- What is the recent revenue and earnings growth for CPL?
- Looking at Chemo-Pharma's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.10%, and quarterly earnings saw a YoY growth of -3.50%.
- How much of CPL stock is held by insiders and institutions?
- Wondering who owns Chemo-Pharma stock? Company insiders (like executives and directors) hold about 70.34% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.